ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Cardiol Therapeutics Inc

Cardiol Therapeutics Inc (CRDL)

2.13
0.05
(2.40%)
Closed July 13 3:00PM
2.05
-0.08
(-3.76%)
After Hours: 5:01PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.050.050.050.050.000.00 %502,5047/12/2024
5.000.050.050.050.050.000.00 %0507-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.251.000.440.625-0.11-20.00 %10287/12/2024
5.002.454.400.003.4250.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
US$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
US$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
US$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
US$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
US$ 9.11
(51.33%)
7.4M
SISIShineco Inc
US$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
US$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
US$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
US$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
US$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
US$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
US$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
US$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
US$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
US$ 4.25
(25.00%)
167.79M

CRDL Discussion

View Posts
jobynimble jobynimble 1 day ago
CRDL grabbed some July19 2.50 calls at a nickel, lotto play, chart looking betterโ€ฆ
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 2 weeks ago
Good!
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 2 weeks ago
Higher lows...still bullish
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
I like!
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
>$4 likely
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
Back to $3?
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
There's volume...looks like run will continue
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
Yeah...we need to keep plenty of rainy day cash in the jar lol
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
Tough week, no doubt
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
My portfolio is in a depression at the moment...may have to eat dirt ala mode for dinner tonight
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
There will not be one until after they submit which wu probably be around $1-$1.50 area
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
RGDL too high too fast...will wait on pullback
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
Will look at it...watch CDRL go lower now that I text you...I bet I jinxed it lol
🤪 1
Tiger Money Tiger Money 3 weeks ago
Nice. $RDGL about to go up big time!
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
Morning...there are signs this is stablizing...both my CRDL and WMT calls are green this morning

Im finding more and more playing options
are the way to go if careful
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
No doubt
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
...all depends which way the wind blows
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
It looks excessive but wouldnโ€™t be surprised to see the $1-1.50 range after it run up with $2 being the area it settles in before its first leg up following this downturn
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
Im thinking they're diluting because they need money for phase 3 trial...otherwise I dont know why the huge sell off
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 weeks ago
1.50 could be bottom but 1.75 more likely
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 weeks ago
$1 bid here if my $1.50โ€™s get filled
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 4 weeks ago
Nice
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
I got em...bought 10
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 4 weeks ago
Agreed
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
Nah...it only allows .05 increments...bidding .15...dont want to bid .20...if doesnt fill will let it go and buy something else...tomorrow is a stock mkt holiday and its summer so a weak mkt is expected
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 4 weeks ago
Gm- u get filled?
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
GM... bidding 6/19 2.50 calls @.15
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 4 weeks ago
Iโ€™m adding about 500-1k a day for the next couple of weeks
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
I added a little today...already have plenty...we will do quite well when thos recovers...surprised this crashed
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
The wrecking ball hit my portflio this morning lol...I'm holding...will wait out this dip
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 4 weeks ago
Added this morning and adding more now
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
Hey we're way oversold here...please add
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 4 weeks ago
Yeah they have a low float...so quite volatile
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Jump all over this...treat the dip as your friend
🎯 1
jobynimble jobynimble 1 month ago
CRDL, the old buy-the-rumor, sell-the-newsโ€ฆ

Biotechs get big swings, doesnโ€™t mean CRDL wonโ€™t work out longer termโ€ฆ
👍️ 1
G-star G-star 1 month ago
What is happening, why the deep plunge?
๐Ÿ‘๏ธ0
Mrogers23 Mrogers23 1 month ago
$CRDL Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

https://finance.yahoo.com/news/cardiol-therapeutics-announces-positive-topline-115800368.html
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 month ago
CRDL new 52 week high
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Welcome to the Cardiol Therapeutics hotel...our guests sleep well here
👍️ 1
jobynimble jobynimble 1 month ago
Cardiol Therapeutics (NASDAQ:CRDL) is a Canadian biotech drug developer focused on developing their novel ultrapure cannabidiol formulation, CardiolRx™, for rare inflammatory heart diseases, specifically recurrent pericarditis and acute myocarditis.

Pericarditis is characterized as inflammation of the pericardium, layers of tissue that surround the heart, that affects about 165,000 people in the U.S. annually and has no first-line FDA-approved treatment. Among those treated for acute pericarditis, 15% to 30% may experience recurrent pericarditis.

Currently, anti-inflammatory drugs such as colchicine are prescribed for pericarditis treatment in cases of chronic or recurrent pericarditis. If the patient with pericarditis disease does not respond to anti-inflammatory medications, corticosteroids such as prednisone are prescribed.

More recently, Kiniksa Pharmaceuticalsโ€™ ARCALYST® (rilonacept) became the first and only FDA-approved treatment indicated for the treatment of recurrent pericarditis and the reduction in risk of recurrence in adults and children 12 years and older.

ARCALYST is a weekly subcutaneous injection, whereas CardiolRx™ is an oral drug taken twice daily which is a major advantage as the idea of weekly injections could not be as appealing to patients.

Cardiol Therapeuticsโ€™ (NASDAQ:CRDL) pre-clinical models showed that by inhibiting activation of the NLRP3 inflammasome pathway, cannabidiol may help resolve the symptoms of pericarditis.

This approach has already demonstrated incredible potential, as the company was granted Orphan Drug Designation (ODD) by the U.S. FDA for the treatment of pericarditis, which includes recurrent pericarditis.

Cardiol Therapeutics followed this major achievement with completing enrollment in its Phase 2, open-label MAvERIC-Pilot study investigating the tolerance, safety, and effect of CardiolRx™ in patients with recurrent pericarditis. The primary endpoint of the trial is the change in patient-reported pericarditis pain using an 11-point numeric rating scale (NRS) from baseline to week 8 with topline results expected in early June.

Not only that, Cardiol Therapeutics recently presented its concurrent Phase II ARCHER trial design at the annual congress of the Heart Failure Association of the European Society of Cardiology. This demonstrated the high level of interest from the cardiology community in novel approaches to treat acute myocarditis, for which there are currently no therapies approved by European and US regulatory authorities.

The ARCHER trial is expected to enroll 100 patients at pre-eminent cardiovascular research centers in the United States, Canada, France, Brazil, and Israel. Patient recruitment has been accelerating due in large part to the growing global awareness of myocarditis, and ARCHER has already exceeded 85% of target enrollment.

Cardiol Therapeutics (NASDAQ:CRDL) expects that results from the ARCHER trial will assist in furthering its understanding of the therapeutic potential of CardiolRx™ and will complement the more advanced MAvERIC-Pilot Phase II study in patients with recurrent pericarditis.

Just to put the opportunity here in context, Future Market Insights expects that the worldwide pericarditis treatment market is likely to be worth $ 6 billion by 2032. ARCALYSTโ€™s sales further reaffirm this considering that the drugโ€™s 2023 net revenue grew 90% year-over-year to $233.1 million.

Several analysts have maintained their positive outlook on the company and have high hopes that the June data will further prove CardiolRx™ efficacy in treating recurrent pericarditis. In fact, Joe Gantoss of Chimera Research Group notes, โ€œI wonโ€™t be surprised to see the price breaking out the 3-year high at $4.96 if the recurrent-pericarditis data show a clear success and open the path to move to the next stage with Phase-3 trial,โ€ while analysts at H.C Wainwright & Co. issued a $9 price target for the stock.
👍️ 1
jobynimble jobynimble 1 month ago
https://www.theglobeandmail.com/investing/markets/markets-news/TheNewswire.com/26745778/surging-biotech-ma-reaffirms-massive-opportunity-in-rare-disease-drug-development/
👍️ 1
TrendTrade2016 TrendTrade2016 1 month ago
First in first out
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Are you picking your nose on this one? You aren't posting...Am I the only one cleaning up here?
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Ripping!
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Will recover next week
๐Ÿ‘๏ธ0
Hitman970 Hitman970 1 month ago
Dip and rip!!!!$$$$
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
$4 easy then 5
๐Ÿ‘๏ธ0
Hitman970 Hitman970 1 month ago
EPIC CALL!!!$$$
๐Ÿ‘๏ธ0
Hitman970 Hitman970 1 month ago
Buy and hold
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 1 month ago
Rock on...
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock